Case Studies & Whitepapers2024-09-18
From R&D to Phase III: Peptide 39AA Project Completed in 10 Months
With strict project planning and implementation, the research and development of 45AA straight chain peptide was completed in 2 months, and the subsequent production and quality testing of non-GMP (300g) and GMP (1kg) batches were successfully completed in the following 8 months.
The maximum single impurity of the final product does not exceed 0.5%, and the total yield reaches 30%. All manufacturing and quality control are carried out in accordance with GMP requirements, ensuring the q
More
News
More
Case Studies & Whitepapers2026-09-25
Dual-Payload Conjugates: Addressing the CMC Challenges of a New Therapeutic Approach
Dual-payload conjugates—two mechanistically distinct payloads carried on a single targeting vehicle—represent the next technological frontier beyond conventional ADCs.
Case Studies & Whitepapers2026-09-21
PMO Therapeutics: Technical Review and Manufacturing Platform Capabilities
This article offers a systematic overview of PMO drug technology covering underlying principles, manufacturing workflows, and therapeutic prospects.
